Patents for A61K 49 - Preparations for testing in vivo (35,376)
04/2010
04/08/2010US20100086486 Genetically modified human natural killer cell lines
04/08/2010US20100086485 Influenza vaccine
04/08/2010US20100086484 In vivo drug concentration distribution measuring device, variable-wavelength filter used for the same, and in vivo drug concentration distribution measuring method
04/08/2010US20100086483 Method of multidetector computed tomagraphy
04/08/2010US20100086482 Divergent synthesis of looped poly(ester)-and poly(ether)-substituted dendrons and dendrimers
04/08/2010US20100086481 Differential expression of molecules associated with intra-cerebral hemorrhage
04/08/2010DE102008049771A1 Kombiniertes Magnetresonanz-Bildgebungs- und Zielführungsgerät für magnetische Partikel Combined magnetic resonance imaging and navigation device for magnetic particles
04/08/2010CA2738786A1 A version of fdg detectable by single-photon emission computed tomography
04/07/2010EP2172551A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
04/07/2010EP2172444A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group
04/07/2010EP2170407A2 Imaging medium comprising hyperpolarised 13c-lactate and use thereof
04/07/2010EP2170406A2 A method of hyperpolarising a magnetic resonance agent
04/07/2010EP2170405A2 Imaging diagnostics by combining contrast agents
04/07/2010EP2170401A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily
04/07/2010CN101023945B Use of non-periphery substituted phthalocyaniu metal complex
04/06/2010US7692002 to coordinate vitamin B12 through its cyanide to a metal to form a [Co]-CN-M complex, wherein [Co] represents vitamin B12 without cyanide; such vitamin B12 derivatives are chemically stable and can be easily produced; e.g. use of precursor complex cis-diamminedichloroplatinum(II)
04/06/2010US7691390 polypeptide and isolated nucleic acid encoding the polypeptide for SARS CoV protein 3a, which can serve as a target for elucidating the mechanisms of SARS and developing vaccines and therapeutics
04/06/2010US7691383 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell
04/06/2010US7691380 Coagulating the vascular systems of cancer cells through site specific delivery of coagulant antibodies causing regression of the cells
04/06/2010US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody
04/06/2010US7691376 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
04/06/2010US7691285 Magnetic nanoparticles having improved magnetic properties
04/01/2010WO2010037122A1 Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods
04/01/2010WO2010037069A2 Dithienopyrrole dyes for imaging and therapy
04/01/2010WO2010037068A2 Dithienofuran dyes for imaging and therapy
04/01/2010WO2010034901A2 Gel adapted for transmitting ultrasound waves, method for making said gel, and bag containing same
04/01/2010US20100080798 Kim-1 antagonists and use to modulate immune system
04/01/2010US20100080759 Method for Forming Nano-bubble
04/01/2010US20100080758 Optical fluorescent imaging
04/01/2010US20100080757 Method of detecting abnormal tissue
04/01/2010CA2738035A1 Dithienopyrrole dyes for imaging and therapy
04/01/2010CA2737915A1 Dithienofuran dyes for imaging and therapy
04/01/2010CA2737077A1 Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods
03/2010
03/31/2010EP2167963A2 Polymeric carriers for immunohistochemistry and in situ hybridization
03/31/2010EP2167139A2 Activatable diagnostic and therapeutic compound
03/31/2010CN201431513Y Rat fatigue test device
03/31/2010CN201431512Y Rat sleep deprivation automatic record test device
03/31/2010CN101687803A Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof
03/31/2010CN101687051A Contrast agents
03/31/2010CN101687050A Methods and materials for identifying the origin of a carcinoma of unknown primary origin
03/31/2010CN101687047A Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
03/31/2010CN101687040A Integrated photoactive small molecules and uses thereof
03/31/2010CN101683534A Method for screening qi and blood circulation promotion Chinese medicament components
03/31/2010CN101683272A Ultrasonic sensitive medicament-carried nanometer bubble
03/30/2010US7689267 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
03/30/2010US7687682 Screening for angiogenesis factor; cell apoptosis
03/30/2010US7687607 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS)
03/30/2010US7687265 Foxn1 and pigmentation
03/30/2010US7687053 Embolic compositions with non-cyanoacrylate rheology modifying agents
03/30/2010CA2263765C Methods for the production of protein particles useful for delivery of pharmacological agents
03/30/2010CA2241604C Mesothelium antigen and methods and kits for targeting it
03/30/2010CA2171207C Methods for regulating gastrointestinal motility
03/30/2010CA2170523C Cloned glutamic acid decarboxylase
03/25/2010WO2010033861A1 Optical method for the detection of alzheimer's disease
03/25/2010WO2010032833A1 Molecular probe precursor for imaging of pancreatic islet, and use thereof
03/25/2010WO2010032509A1 Molecular probe precursor for imaging of pancreatic islet, and use thereof
03/25/2010WO2010031578A1 Method for determining the anti-tumor efficacy of monoclonal antibodies
03/25/2010WO2010031168A1 HETERO-MULTIVALENT BINDING AGENTS FOR MEMBERS OF THE TGFβ SUPERFAMILY
03/25/2010WO2010005697A3 18f-labelled three-and four-carbon acids for pet imaging
03/25/2010WO2009155335A3 Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization
03/25/2010WO2009133362A3 Agents for detecting and imaging cell death
03/25/2010US20100076175 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
03/25/2010US20100076174 ErbB Interface Peptidomimetics And Methods Of Use Thereof
03/25/2010US20100074953 Methods for intiating in situ formation of hydrogels
03/25/2010US20100074848 X-ray contrast agent using gold nanoparticles and process for preparing the same
03/25/2010US20100074847 Chromophore Probes for Optical Imaging
03/25/2010US20100074846 Campylobacter Vaccines and Methods of use
03/25/2010US20100074845 Enhanced sensitivity carbon nanotubes as targeted photoacoustic molecular imaging agents
03/25/2010US20100074842 Technetium-99m (I) Tricarbonyl Complexes with Tridentate Chelators for Myocardium Imaging
03/25/2010CA2735869A1 Optical method for the detection of alzheimer's disease
03/25/2010CA2735298A1 Method for determining the anti-tumor efficacy of monoclonal antibodies
03/24/2010EP2166107A1 Lentiviral vectors for the expression of shRNA
03/24/2010EP2164523A2 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function
03/24/2010EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease
03/24/2010CN101680934A Hyperpolarization of compounds for nmr, in particular by means of phip
03/24/2010CN101679510A Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label
03/24/2010CN101678128A Magnetic resonance imaging
03/24/2010CN101678127A Measurement of neural activity
03/24/2010CN101678123A Compositions that include a hydrophobic compound and a polyamino acid conjugate
03/24/2010CN101678118A Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
03/24/2010CN101678047A Remedy and diagnostic for mitochondrial dysfunction brain disease
03/24/2010CN101676300A Antibody for inhibitting growth of colorectal carcinoma and its use in preparation of diagnostic agent of adenocarcinoma
03/24/2010CN101676255A Synthetic method of iodized vegetable fatty acids and their esters
03/24/2010CN101675995A 10-hydroxycamptothecinreagent-delivery lipid ultrasound microbubble agent and its preparation method
03/24/2010CN100594942C Method for preparing cellulose contrast medium for stomach and intestine ultrasonic imaging
03/23/2010US7684852 System, formulation, kit and method for tagging colonic residue in an individual
03/23/2010US7682613 Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
03/23/2010US7682603 Infrared emission agent; therapy, diagnosis of disease
03/23/2010US7682602 Near-infrared fluorescent contrast medium
03/23/2010CA2491572C Abuse-deterrent pharmaceutical compositions of opiods and other drugs
03/23/2010CA2408992C Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
03/23/2010CA2401000C Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
03/23/2010CA2375374C Induction of pharmacological stress with adenosine receptor agonists
03/23/2010CA2332488C Cells and animals deficient in protein kinase c epsilon
03/18/2010WO2010030783A1 Methods for the administration of iloperidone
03/18/2010WO2010030119A2 Fluorescent silica nanoparticles for detecting lymph node and the identification method of lymph node using thereof
03/18/2010WO2010029947A1 Contrast medium composition and process for producing same
03/18/2010WO2010029760A1 Imaging agents of fibrotic diseases
03/18/2010WO2010029500A1 Chelating amphiphilic polymers
03/18/2010WO2010029469A1 Drug carrier providing mri contrast enhancement